{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:42:33Z","timestamp":1789868553574,"version":"4.0.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tumour necrosis factor receptor-associated factor 6 (TRAF6) is a ubiquitin E3 ligase that regulates important biological processes. However, the role of TRAF6 in cardiac hypertrophy remains unknown. Here, we show that TRAF6 levels are increased in human and murine hypertrophied hearts, which is regulated by reactive oxygen species (ROS) production. Cardiac-specific <jats:italic>Traf6<\/jats:italic> overexpression exacerbates cardiac hypertrophy in response to pressure overload or angiotensin II (Ang II) challenge, whereas Traf6 deficiency causes an alleviated hypertrophic phenotype in mice. Mechanistically, we show that ROS, generated during hypertrophic progression, triggers TRAF6 auto-ubiquitination that facilitates recruitment of TAB2 and its binding to transforming growth factor beta-activated kinase 1 (TAK1), which, in turn, enables the direct TRAF6\u2013TAK1 interaction and promotes TAK1 ubiquitination. The binding of TRAF6 to TAK1 and the induction of TAK1 ubiquitination and activation are indispensable for TRAF6-regulated cardiac remodelling. Taken together, we define TRAF6 as an essential molecular switch leading to cardiac hypertrophy in a TAK1-dependent manner.<\/jats:p>","DOI":"10.1038\/ncomms11267","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T23:51:38Z","timestamp":1464825098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":169,"title":["The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling"],"prefix":"10.1038","volume":"7","author":[{"given":"Yan-Xiao","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Qiong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"BFncomms11267_CR1","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1056\/NEJMra072139","volume":"358","author":"JA Hill","year":"2008","unstructured":"Hill, J. A. & Olson, E. N. Cardiac plasticity. N. Engl. J. Med. 358, 1370\u20131380 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms11267_CR2","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/ncomms4303","volume":"5","author":"DS Jiang","year":"2014","unstructured":"Jiang, D. S. et al. IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat. Commun. 5, 3303 (2014).","journal-title":"Nat. Commun."},{"key":"BFncomms11267_CR3","doi-asserted-by":"publisher","first-page":"E4079","DOI":"10.1073\/pnas.1315587110","volume":"110","author":"C Putinski","year":"2013","unstructured":"Putinski, C. et al. Intrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophy. Proc. Natl Acad. Sci. USA 110, E4079\u2013E4087 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11267_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-2187-8-7","volume":"8","author":"P Xie","year":"2013","unstructured":"Xie, P. TRAF molecules in cell signaling and in human diseases. J. Mol. Signal. 8, 7 (2013).","journal-title":"J. Mol. Signal."},{"key":"BFncomms11267_CR5","doi-asserted-by":"publisher","first-page":"17278","DOI":"10.1074\/jbc.C400063200","volume":"279","author":"LG Xu","year":"2004","unstructured":"Xu, L. G., Li, L. Y. & Shu, H. B. TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis. J. Biol. Chem. 279, 17278\u201317282 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFncomms11267_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jcb.24669","volume":"115","author":"Z Bian","year":"2014","unstructured":"Bian, Z. et al. Disruption of tumor necrosis factor receptor associated factor 5 exacerbates pressure overload cardiac hypertrophy and fibrosis. J. Cell. Biochem. 115, 349\u2013358 (2014).","journal-title":"J. Cell. Biochem."},{"key":"BFncomms11267_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/HYPERTENSIONAHA.115.05469","volume":"66","author":"X Jiang","year":"2015","unstructured":"Jiang, X. et al. Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy. Hypertension 66, 356\u2013367 (2015).","journal-title":"Hypertension"},{"key":"BFncomms11267_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.000080","volume":"6","author":"VG Divakaran","year":"2013","unstructured":"Divakaran, V. G. et al. Tumor necrosis factor receptor-associated factor 2 signaling provokes adverse cardiac remodeling in the adult mammalian heart. Circ. Heart Fail. 6, 535\u2013543 (2013).","journal-title":"Circ. Heart Fail."},{"key":"BFncomms11267_CR9","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","volume":"13","author":"MA Lomaga","year":"1999","unstructured":"Lomaga, M. A. et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015\u20131024 (1999).","journal-title":"Genes Dev."},{"key":"BFncomms11267_CR10","doi-asserted-by":"publisher","first-page":"8766","DOI":"10.1073\/pnas.132636999","volume":"99","author":"A Naito","year":"2002","unstructured":"Naito, A. et al. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc. Natl Acad. Sci. USA 99, 8766\u20138771 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11267_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ncomms1332","volume":"2","author":"Y Mu","year":"2011","unstructured":"Mu, Y. et al. TRAF6 ubiquitinates TGFbeta type I receptor to promote its cleavage and nuclear translocation in cancer. Nat. Commun. 2, 330 (2011).","journal-title":"Nat. Commun."},{"key":"BFncomms11267_CR12","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nature09128","volume":"465","author":"SE Alvarez","year":"2010","unstructured":"Alvarez, S. E. et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465, 1084\u20131088 (2010).","journal-title":"Nature"},{"key":"BFncomms11267_CR13","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1093\/hmg\/ddm237","volume":"16","author":"H Sebban-Benin","year":"2007","unstructured":"Sebban-Benin, H. et al. Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. Hum. Mol. Genet. 16, 2805\u20132815 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"BFncomms11267_CR14","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ni1118","volume":"5","author":"T Kawai","year":"2004","unstructured":"Kawai, T. et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5, 1061\u20131068 (2004).","journal-title":"Nat. Immunol."},{"key":"BFncomms11267_CR15","doi-asserted-by":"publisher","first-page":"7296","DOI":"10.1128\/MCB.00662-08","volume":"28","author":"MY Balkhi","year":"2008","unstructured":"Balkhi, M. Y., Fitzgerald, K. A. & Pitha, P. M. Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Mol. Cell. Biol. 28, 7296\u20137308 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"BFncomms11267_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/HYPERTENSIONAHA.113.02653","volume":"63","author":"DS Jiang","year":"2014","unstructured":"Jiang, D. S. et al. Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy. Hypertension 63, 713\u2013722 (2014).","journal-title":"Hypertension"},{"key":"BFncomms11267_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/383443a0","volume":"383","author":"Z Cao","year":"1996","unstructured":"Cao, Z., Xiong, J., Takeuchi, M., Kurama, T. & Goeddel, D. V. TRAF6 is a signal transducer for interleukin-1. Nature 383, 443\u2013446 (1996).","journal-title":"Nature"},{"key":"BFncomms11267_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.yjmcc.2014.04.020","volume":"74","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Ablation of Akt2 protects against lipopolysaccharide-induced cardiac dysfunction: role of Akt ubiquitination E3 ligase TRAF6. J. Mol. Cell. Cardiol. 74, 76\u201387 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFncomms11267_CR19","first-page":"Ol1826","volume":"59","author":"J Chen","year":"2013","unstructured":"Chen, J., Wang, Z. & Wu, T. Shenqi fuzheng injection improves cvb3-induced myocarditis via inhibiting traf6 expression. Cell. Mol. Biol. (Noisy-le-grand) 59, (Suppl): Ol1826\u2013Ol1834 (2013).","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"BFncomms11267_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.freeradbiomed.2009.10.040","volume":"48","author":"LH Zhu","year":"2010","unstructured":"Zhu, L. H. et al. Puerarin attenuates high-glucose-and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2\/Rac1-dependent signaling. Free Radic. Biol. Med. 48, 471\u2013482 (2010).","journal-title":"Free Radic. Biol. Med."},{"key":"BFncomms11267_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/hc0402.102863","volume":"105","author":"S Hirotani","year":"2002","unstructured":"Hirotani, S. et al. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105, 509\u2013515 (2002).","journal-title":"Circulation"},{"key":"BFncomms11267_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","volume":"133","author":"Y Imai","year":"2008","unstructured":"Imai, Y. et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235\u2013249 (2008).","journal-title":"Cell"},{"key":"BFncomms11267_CR23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/ni1200","volume":"6","author":"A Matsuzawa","year":"2005","unstructured":"Matsuzawa, A. et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 6, 587\u2013592 (2005).","journal-title":"Nat. Immunol."},{"key":"BFncomms11267_CR24","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1128\/MCB.00227-07","volume":"27","author":"G Fujino","year":"2007","unstructured":"Fujino, G. et al. Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1. Mol. Cell. Biol. 27, 8152\u20138163 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"BFncomms11267_CR25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1161\/CIRCRESAHA.109.209007","volume":"106","author":"SA McCalmon","year":"2010","unstructured":"McCalmon, S. A. et al. Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2. Circ. Res. 106, 952\u2013960 (2010).","journal-title":"Circ. Res."},{"key":"BFncomms11267_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/imr.12302","volume":"266","author":"MC Walsh","year":"2015","unstructured":"Walsh, M. C., Lee, J. & Choi, Y. Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol. Rev. 266, 72\u201392 (2015).","journal-title":"Immunol. Rev."},{"key":"BFncomms11267_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s00395-013-0338-0","volume":"108","author":"K Chen","year":"2013","unstructured":"Chen, K. et al. Vinexin-beta protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway. Basic Res. Cardiol. 108, 338 (2013).","journal-title":"Basic Res. Cardiol."},{"key":"BFncomms11267_CR28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/CIRCRESAHA.107.168153","volume":"102","author":"W Min","year":"2008","unstructured":"Min, W. et al. AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation. Circ. Res. 102, 840\u2013848 (2008).","journal-title":"Circ. Res."},{"key":"BFncomms11267_CR29","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1158\/0008-5472.CAN-12-0154","volume":"72","author":"A Pal","year":"2012","unstructured":"Pal, A. et al. CCN6 modulates BMP signaling via the Smad-independent TAK1\/p38 pathway, acting to suppress metastasis of breast cancer. Cancer Res. 72, 4818\u20134828 (2012).","journal-title":"Cancer Res."},{"key":"BFncomms11267_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.it.2013.03.007","volume":"34","author":"AA Ajibade","year":"2013","unstructured":"Ajibade, A. A., Wang, H. Y. & Wang, R. F. Cell type-specific function of TAK1 in innate immune signaling. Trends Immunol. 34, 307\u2013316 (2013).","journal-title":"Trends Immunol."},{"key":"BFncomms11267_CR31","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.molcel.2008.09.002","volume":"31","author":"M Yamashita","year":"2008","unstructured":"Yamashita, M. et al. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol. Cell 31, 918\u2013924 (2008).","journal-title":"Mol. Cell"},{"key":"BFncomms11267_CR32","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/ncb1780","volume":"10","author":"A Sorrentino","year":"2008","unstructured":"Sorrentino, A. et al. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat. Cell Biol. 10, 1199\u20131207 (2008).","journal-title":"Nat. Cell Biol."},{"key":"BFncomms11267_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","volume":"15","author":"A Kanayama","year":"2004","unstructured":"Kanayama, A. et al. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535\u2013548 (2004).","journal-title":"Mol. Cell"},{"key":"BFncomms11267_CR34","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.cellsig.2010.11.017","volume":"23","author":"Y Fan","year":"2011","unstructured":"Fan, Y., Yu, Y., Mao, R., Zhang, H. & Yang, J. TAK1 Lys-158 but not Lys-209 is required for IL-1beta-induced Lys63-linked TAK1 polyubiquitination and IKK\/NF-kappaB activation. Cell Signal. 23, 660\u2013665 (2011).","journal-title":"Cell Signal."},{"key":"BFncomms11267_CR35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.biocel.2009.12.023","volume":"42","author":"M Landstrom","year":"2010","unstructured":"Landstrom, M. The TAK1-TRAF6 signalling pathway. Int. J. Biochem. Cell Biol. 42, 585\u2013589 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFncomms11267_CR36","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1074\/jbc.M609503200","volume":"282","author":"B Lamothe","year":"2007","unstructured":"Lamothe, B. et al. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. J. Biol. Chem. 282, 4102\u20134112 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFncomms11267_CR37","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/01.RES.0000099504.30207.F5","volume":"93","author":"JA Byrne","year":"2003","unstructured":"Byrne, J. A. et al. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 93, 802\u2013805 (2003).","journal-title":"Circ. Res."},{"key":"BFncomms11267_CR38","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1089\/152308603770380034","volume":"5","author":"A Sabri","year":"2003","unstructured":"Sabri, A., Hughie, H. H. & Lucchesi, P. A. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid. Redox Signal. 5, 731\u2013740 (2003).","journal-title":"Antioxid. Redox Signal."},{"key":"BFncomms11267_CR39","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/iub.1078","volume":"64","author":"L Dai","year":"2012","unstructured":"Dai, L., Aye Thu, C., Liu, X. Y., Xi, J. & Cheung, P. C. TAK1 more than just innate immunity. IUBMB Life 64, 825\u2013834 (2012).","journal-title":"IUBMB Life"},{"key":"BFncomms11267_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/hr.2011.196","volume":"35","author":"SJ Watkins","year":"2012","unstructured":"Watkins, S. J., Borthwick, G. M., Oakenfull, R., Robson, A. & Arthur, H. M. Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2\/3-independent. Hypertens. Res. 35, 393\u2013398 (2012).","journal-title":"Hypertens. Res."},{"key":"BFncomms11267_CR41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cardiores.2005.11.007","volume":"69","author":"SJ Watkins","year":"2006","unstructured":"Watkins, S. J., Jonker, L. & Arthur, H. M. A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy. Cardiovasc. Res. 69, 432\u2013439 (2006).","journal-title":"Cardiovasc. Res."},{"key":"BFncomms11267_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/HYPERTENSIONAHA.110.149963","volume":"56","author":"H Huang","year":"2010","unstructured":"Huang, H. et al. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling. Hypertension 56, 232\u2013239 (2010).","journal-title":"Hypertension"},{"key":"BFncomms11267_CR43","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/75037","volume":"6","author":"D Zhang","year":"2000","unstructured":"Zhang, D. et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat. Med. 6, 556\u2013563 (2000).","journal-title":"Nat. Med."},{"key":"BFncomms11267_CR44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1097-2765(00)80244-0","volume":"5","author":"G Takaesu","year":"2000","unstructured":"Takaesu, G. et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 5, 649\u2013658 (2000).","journal-title":"Mol. Cell"},{"key":"BFncomms11267_CR45","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature08247","volume":"461","author":"ZP Xia","year":"2009","unstructured":"Xia, Z. P. et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461, 114\u2013119 (2009).","journal-title":"Nature"},{"key":"BFncomms11267_CR46","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1161\/CIRCULATIONAHA.114.011195","volume":"130","author":"L Li","year":"2014","unstructured":"Li, L. et al. Transforming growth factor beta-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling. Circulation 130, 2162\u20132172 (2014).","journal-title":"Circulation"},{"key":"BFncomms11267_CR47","doi-asserted-by":"publisher","first-page":"11677","DOI":"10.1073\/pnas.0603089103","volume":"103","author":"HH Liu","year":"2006","unstructured":"Liu, H. H., Xie, M., Schneider, M. D. & Chen, Z. J. Essential role of TAK1 in thymocyte development and activation. Proc. Natl Acad. Sci. USA 103, 11677\u201311682 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11267_CR48","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/ni1255","volume":"6","author":"S Sato","year":"2005","unstructured":"Sato, S. et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087\u20131095 (2005).","journal-title":"Nat. Immunol."},{"key":"BFncomms11267_CR49","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1242\/dev.02333","volume":"133","author":"JL Jadrich","year":"2006","unstructured":"Jadrich, J. L., O\u2019Connor, M. B. & Coucouvanis, E. The TGF beta activated kinase TAK1 regulates vascular development in vivo. Development 133, 1529\u20131541 (2006).","journal-title":"Development"},{"key":"BFncomms11267_CR50","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1083\/jcb.153.4.687","volume":"153","author":"K Monzen","year":"2001","unstructured":"Monzen, K. et al. Smads, TAK1, and their common target ATF-2 play a critical role in cardiomyocyte differentiation. J. Cell Biol. 153, 687\u2013698 (2001).","journal-title":"J. Cell Biol."},{"key":"BFncomms11267_CR51","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrm2262","volume":"8","author":"P ten Dijke","year":"2007","unstructured":"ten Dijke, P. & Arthur, H. M. Extracellular control of TGFbeta signalling in vascular development and disease. Nat. Rev. Mol. Cell. Biol. 8, 857\u2013869 (2007).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"BFncomms11267_CR52","doi-asserted-by":"publisher","first-page":"19610","DOI":"10.1074\/jbc.M603384200","volume":"281","author":"E Omori","year":"2006","unstructured":"Omori, E. et al. TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J. Biol. Chem. 281, 19610\u201319617 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFncomms11267_CR53","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1128\/MCB.06351-11","volume":"32","author":"PK Paul","year":"2012","unstructured":"Paul, P. K. et al. The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Mol. Cell. Biol. 32, 1248\u20131259 (2012).","journal-title":"Mol. Cell. Biol."},{"key":"BFncomms11267_CR54","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1073\/pnas.1015081108","volume":"108","author":"DJ Cao","year":"2011","unstructured":"Cao, D. J. et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc. Natl Acad. Sci. USA 108, 4123\u20134128 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11267_CR55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/HYPERTENSIONAHA.114.03229","volume":"64","author":"DS Jiang","year":"2014","unstructured":"Jiang, D. S. et al. Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload. Hypertension 64, 77\u201386 (2014).","journal-title":"Hypertension"},{"key":"BFncomms11267_CR56","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/HYPERTENSIONAHA.113.01506","volume":"63","author":"DS Jiang","year":"2014","unstructured":"Jiang, D. S. et al. Signal regulatory protein-alpha protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling. Hypertension 63, 96\u2013104 (2014).","journal-title":"Hypertension"},{"key":"BFncomms11267_CR57","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/aps.2012.164","volume":"34","author":"YQ Li","year":"2013","unstructured":"Li, Y. Q. et al. Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice. Acta Pharmacol. Sin. 34, 352\u2013359 (2013).","journal-title":"Acta Pharmacol. Sin."},{"key":"BFncomms11267_CR58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/cvr\/cvu004","volume":"102","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Dickkopf-3 attenuates pressure overload-induced cardiac remodelling. Cardiovasc. Res. 102, 35\u201345 (2014).","journal-title":"Cardiovasc. Res."},{"key":"BFncomms11267_CR59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cvr\/cvt232","volume":"101","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice. Cardiovasc. Res. 101, 87\u201396 (2014).","journal-title":"Cardiovasc. Res."},{"key":"BFncomms11267_CR60","doi-asserted-by":"publisher","first-page":"13818","DOI":"10.1073\/pnas.1008397107","volume":"107","author":"H Li","year":"2010","unstructured":"Li, H. et al. Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload. Proc. Natl Acad. Sci. USA 107, 13818\u201313823 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11267_CR61","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/HYPERTENSIONAHA.113.02083","volume":"63","author":"DS Jiang","year":"2014","unstructured":"Jiang, D. S. et al. Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin. Hypertension 63, 119\u2013127 (2014).","journal-title":"Hypertension"},{"key":"BFncomms11267_CR62","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.4049\/jimmunol.181.7.5098","volume":"181","author":"IT Lee","year":"2008","unstructured":"Lee, I. T. et al. Lipoteichoic acid induces HO-1 expression via the TLR2\/MyD88\/c-Src\/NADPH oxidase pathway and Nrf2 in human tracheal smooth muscle cells. J. Immunol. 181, 5098\u20135110 (2008).","journal-title":"J. Immunol."},{"key":"BFncomms11267_CR63","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.niox.2005.11.008","volume":"14","author":"HJ Chae","year":"2006","unstructured":"Chae, H. J. et al. Catalase protects cardiomyocytes via its inhibition of nitric oxide synthesis. Nitric Oxide 14, 189\u2013199 (2006).","journal-title":"Nitric Oxide"},{"key":"BFncomms11267_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/cvr\/cvs309","volume":"97","author":"J Ma","year":"2013","unstructured":"Ma, J. et al. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways. Cardiovasc. Res. 97, 77\u201387 (2013).","journal-title":"Cardiovasc. Res."},{"key":"BFncomms11267_CR65","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1182\/blood-2004-09-3662","volume":"106","author":"NK Lee","year":"2005","unstructured":"Lee, N. K. et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106, 852\u2013859 (2005).","journal-title":"Blood"},{"key":"BFncomms11267_CR66","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2006.11.013","volume":"42","author":"S Deng","year":"2007","unstructured":"Deng, S. et al. Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH. Free Radic. Biol. Med. 42, 466\u2013473 (2007).","journal-title":"Free Radic. Biol. Med."},{"key":"BFncomms11267_CR67","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbadis.2009.10.014","volume":"1802","author":"E Borchi","year":"2010","unstructured":"Borchi, E. et al. Enhanced ROS production by NADPH oxidase is correlated to changes in antioxidant enzyme activity in human heart failure. Biochim. Biophys. Acta 1802, 331\u2013338 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFncomms11267_CR68","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S0008-6363(03)00499-1","volume":"59","author":"F Moritz","year":"2003","unstructured":"Moritz, F. et al. Role of reactive oxygen species in cocaine-induced cardiac dysfunction. Cardiovasc. Res. 59, 834\u2013843 (2003).","journal-title":"Cardiovasc. Res."},{"key":"BFncomms11267_CR69","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00395-012-0326-9","volume":"108","author":"J Lu","year":"2013","unstructured":"Lu, J. et al. Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy. Basic Res. Cardiol. 108, 326 (2013).","journal-title":"Basic Res. Cardiol."},{"key":"BFncomms11267_CR70","doi-asserted-by":"publisher","first-page":"e1004358","DOI":"10.1371\/journal.ppat.1004358","volume":"10","author":"Y Qin","year":"2014","unstructured":"Qin, Y. et al. RNF26 temporally regulates virus-triggered type I interferon induction by two distinct mechanisms. PLoS Pathog. 10, e1004358 (2014).","journal-title":"PLoS Pathog."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms11267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms11267","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms11267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:30:39Z","timestamp":1672831839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms11267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,1]]}},"alternative-id":["BFncomms11267"],"URL":"https:\/\/doi.org\/10.1038\/ncomms11267","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]},"assertion":[{"value":"9 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11267"}}